Heike Hofmann-Winkler

发表

Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2

Lennart M. Reinke, L. Reinke, M. Spiegel, 2017, PloS one.

TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein

O. Jahn, Stefanie Gierer, Heike Hofmann-Winkler, 2013, Journal of Virology.

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

H. Jäck, Inga Nehlmeier, M. Hoffmann, 2021, bioRxiv.

Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response to SARS-CoV-2 infection

M. Bauer, S. Coldewey, O. Moerer, 2021, Clinical science.

The RNA demethylase FTO controls m6A marking on SARS-CoV-2 and classifies COVID-19 severity in patients

D. Lambrechts, L. Naesens, Jana Jeschke, 2022, bioRxiv.

Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia

Stefanie Gierer, Heike Hofmann-Winkler, S. Pöhlmann, 2013, Emerging infectious diseases.

Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

S. Ciesek, H. Scheiblauer, G. Rohde, 2020, The Journal of Infectious Diseases.

Analysis of humoral immune responses in SARS-CoV-2 infected patients

S. Ciesek, H. Scheiblauer, G. Rohde, 2020, The Journal of infectious diseases.

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

M. Müller, C. Drosten, M. Hoffmann, 2020, Nature.

TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells

Heike Hofmann-Winkler, S. Pöhlmann, P. Zmora, 2015, PloS one.

SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades 1 antibodies induced by infection and vaccination

H. Jäck, Inga Nehlmeier, M. Hoffmann, 2021 .

Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation

S. Kramer, C. Stephani, O. Moerer, 2020, Critical care explorations.

Interaction of Human Cytomegalovirus Tegument Proteins ppUL35 and ppUL35A with Sorting Nexin 5 Regulates Glycoprotein B (gpUL55) Localization

Heike Hofmann-Winkler, M. Winkler, H. Fickenscher, 2018, Journal of Virology.

Primate Simplexviruses Differ in Tropism for Macaque Cells

Heike Hofmann-Winkler, M. Winkler, S. Pöhlmann, 2022, bioRxiv.

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

L. K. Sørensen, F. Noé, Jason M. Sheltzer, 2021, EBioMedicine.

Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

L. K. Sørensen, F. Noé, Jason M. Sheltzer, 2020, bioRxiv.

Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins

M. Hoffmann, Heike Hofmann-Winkler, S. Pöhlmann, 2018, Activation of Viruses by Host Proteases.

Evidence that Processing of the Severe Fever with Thrombocytopenia Syndrome Virus Gn/Gc Polyprotein Is Critical for Viral Infectivity and Requires an Internal Gc Signal Peptide

M. Spiegel, Teresa Plegge, Heike Hofmann-Winkler, 2016, PloS one.

SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization

H. Jäck, S. Nessler, M. Hoffmann, 2021, bioRxiv.

Importance of Covalent and Noncovalent SUMO Interactions with the Major Human Cytomegalovirus Transactivator IE2p86 for Viral Infection

Heike Hofmann-Winkler, T. Stamminger, Nina Tavalai, 2009, Journal of Virology.

TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium

M. Habjan, Stefanie Gierer, Heike Hofmann-Winkler, 2013, Journal of Virology.

Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies

M. Bauer, O. Moerer, Heike Hofmann-Winkler, 2021, Frontiers in Immunology.

Host Cell Factors in Filovirus Entry: Novel Players, New Insights

Heike Hofmann-Winkler, S. Pöhlmann, F. Kaup, 2012, Viruses.

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

H. Jäck, J. Münch, M. Hoffmann, 2021, Cell.

Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination

R. Blasczyk, B. Eiz-Vesper, M. Hoeper, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.

R. Blasczyk, B. Eiz-Vesper, M. Hoeper, 2021, medRxiv.

SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination

H. Jäck, J. Münch, M. Hoffmann, 2021, bioRxiv.

Analysis of Ebola Virus Entry Into Macrophages

G. Herrler, W. Jahnen-Dechent, S. Becker, 2015, Journal of Infectious Diseases.

Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase

T. Wolff, M. Schindler, Inga Nehlmeier, 2015, Journal of Virology.

Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study

C. Stadelmann, O. Moerer, Heike Hofmann-Winkler, 2021, Frontiers in Medicine.

TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium

M. Habjan, Stefanie Gierer, Heike Hofmann-Winkler, 2013, Journal of Virology.

Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976

Heike Hofmann-Winkler, S. Pöhlmann, Kerstin Gnirss, 2015, The Journal of infectious diseases.